Comparative efficacy and safety of pharmacological interventions for severe COVID-19 patients: An updated network meta-analysis of 48 randomized controlled trials

To date, there has been little agreement on what drug is the "best" drug for treating severe COVID-19 patients. This study aimed to assess the efficacy and safety of different medications available at present for severe COVID-19. METHODS: We searched databases for randomized controlled tri...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Qinglin, Zhao, Gang, Chen, Junfang, Jia, Qingjun, Fang, Zijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575403/
https://www.ncbi.nlm.nih.gov/pubmed/36254081
http://dx.doi.org/10.1097/MD.0000000000030998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575403/
https://www.ncbi.nlm.nih.gov/pubmed/36254081
http://dx.doi.org/10.1097/MD.0000000000030998

Ejemplares similares